Company: CDLX
Filing Date: 2025-05-20
Form Type: 8-K
Source: 0001666071-25-000075
Chunk: 3

Company: Cardlytics, Inc.
Filing Date: 2025-05-20
Form: 8-K
Item: Item 9.01
Chunk 3
---
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

  Exhibit      Exhibit Description                                                                                                                                                                     
      104      The cover page from Cardlytics, Inc.’s Form 8-K filed on May 20, 2025, formatted in Inline XBRL.                                                                                        
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      2025 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Exercise, Stock Option Grant Notice, Restricted Stock Unit Notice and Restricted Stock Agreement thereunder.  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                               Cardlytics, Inc.                                                    
  Date:      May 20, 2025      By:                   /s/ Alexis DeSieno                            
                                                     Alexis DeSieno                                
                                                     Chief Financial Officer